Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
Deloitte
Mallinckrodt
US Army
US Department of Justice
Chubb
Covington
Dow

Generated: December 9, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ALLOPURINOL; LESINURAD

« Back to Dashboard

Clinical Trials for Allopurinol; Lesinurad

Trial ID Title Status Sponsor Phase Summary
NCT01493531 Combining Lesinurad With Allopurinol in Inadequate Responders Completed Ardea Biosciences, Inc. Phase 3 This study will compare the serum uric acid lowering effects, clinical benefits, and safety of lesinurad in combination with allopurinol to allopurinol alone in subjects with gout who have had an inadequate response to allopurinol.
NCT01508702 Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors Completed Ardea Biosciences, Inc. Phase 3 This study will assess the serum uric acid lowering effects and safety of lesinurad compared to placebo in patients who are intolerant or have a contraindication to allopurinol or febuxostat.
NCT01510158 Combining Lesinurad With Allopurinol in Inadequate Responders Completed Ardea Biosciences, Inc. Phase 3 This study that compare the serum uric acid lowering effects, clinical benefits, and safety of lesinurad in combination with allopurinol to allopurinol alone in subjects with gout who have had an inadequate response to allopurinol.
NCT01808131 Lesinurad and Allopurinol Combination Extension Study in Gout Active, not recruiting Ardea Biosciences, Inc. Phase 3 This study will assess the serum uric acid lowering effects and safety of lesinurad in combination with allopurinol over a long-term timeframe.
NCT02581553 Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability Completed Ardea Biosciences, Inc. Phase 1 This study will assess relative bioavailability of lesinurad/allopurinol fixed dose combination (FDC), its individual components and the effect of food.
NCT02888054 Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence Active, not recruiting Ardea Biosciences, Inc. Phase 1 This study will assess the bioequivalence (BE) of Lesinurad/Allopurinol Fixed-Dose Combination (FDC) Tablets and Coadministered Lesinurad and Allopurinol Tablets in Fed Healthy Adult Subjects
NCT03272425 Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence. Enrolling by invitation Ardea Biosciences, Inc. Phase 1 To assess the bioequivalence between lesinurad/allopurinol 200/300 FDC tablets and coadministered lesinurad and allopurinol tablets in the fasted state based on the pharmacokinetic (PK) evaluation of lesinurad and allopurinol in healthy adult subjects.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Allopurinol; Lesinurad

Condition Name

Condition Name for Allopurinol; Lesinurad
Intervention Trials
Gout 5
Healthy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Allopurinol; Lesinurad
Intervention Trials
Gout 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Allopurinol; Lesinurad

Trials by Country

Trials by Country for Allopurinol; Lesinurad
Location Trials
United States 138
South Africa 12
Canada 12
Australia 11
New Zealand 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Allopurinol; Lesinurad
Location Trials
Texas 6
Arkansas 4
Ohio 4
Oklahoma 4
Pennsylvania 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Allopurinol; Lesinurad

Clinical Trial Phase

Clinical Trial Phase for Allopurinol; Lesinurad
Clinical Trial Phase Trials
Phase 3 4
Phase 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Allopurinol; Lesinurad
Clinical Trial Phase Trials
Completed 4
Active, not recruiting 2
Enrolling by invitation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Allopurinol; Lesinurad

Sponsor Name

Sponsor Name for Allopurinol; Lesinurad
Sponsor Trials
Ardea Biosciences, Inc. 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Allopurinol; Lesinurad
Sponsor Trials
Industry 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Deloitte
Cantor Fitzgerald
Fuji
Cipla
Mallinckrodt
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.